Sugi Predict

Sugi Predict / Compounds / SCHEMBL161573

SCHEMBL161573

SCHEMBL161573

[c]1ccc(-n2ccnc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 4/20 0.63
▸ LMNA P02545 1/20 0.59
▸ MAPT P10636 1/20 0.59
▸ ENPP2 Q13822 1/20 0.59
▸ MKNK1 Q9BUB5 1/20 0.59
▸ MKNK2 Q9HBH9 1/20 0.59
▸ NOTUM Q6P988 1/20 0.59
▸ MEN1 O00255 1/20 0.55
▸ ALOX15 P16050 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ CYP2A6 P11509 1/20 0.52
▸ BAZ2B Q9UIF8 1/20 0.50
▸ CYP51A1 Q16850 1/20 0.49
▸ ADH5 P11766 2/20 0.47
▸ CYP19A1 P11511 3/20 0.47
▸ IDO1 P14902 1/20 0.47
▸ CYP11B1 P15538 1/20 0.47
▸ CYP11B2 P19099 1/20 0.47
▸ CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28046791 0.98 CYP3A4 (0.61) CYP3A4LMNAMAPTENPP2MKNK1
SCHEMBL28046718 0.98 CYP3A4 (0.61) CYP3A4LMNAMAPTENPP2MKNK1
SCHEMBL28046790 0.98 CYP3A4 (0.61) CYP3A4LMNAMAPTENPP2MKNK1
SCHEMBL27862724 0.98 CYP3A4 (0.61) CYP3A4LMNAMAPTENPP2MKNK1
SCHEMBL11366419 0.88 LMNA (0.51) CYP3A4LMNAMAPTENPP2MKNK1
SCHEMBL2532397 0.84 LMNA (0.78) CYP3A4LMNAMAPTENPP2MKNK1
Hydrochloric Acid SCHEMBL28701756 0.81 LMNA (0.75) CYP3A4LMNAMAPTENPP2MKNK1
SCHEMBL27879881 0.80 PDE3B (0.49) CYP3A4LMNAMAPTENPP2MKNK1
SCHEMBL3250899 0.79 CYP3A4 (0.71) CYP3A4LMNAMAPTENPP2MKNK1
SCHEMBL451 0.77 CYP3A4 (1.00) CYP3A4LMNAMAPTENPP2MKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1070 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174603-A1 MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME RAPPTA THERAPEUTICS OY (FI) 2024-05-30 — — US claimed
EP-4288412-A1 MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME Rappta Therapeutics Oy (FI) 2023-12-13 — — EP claimed
WO-2023230217-A1 ANTILEISHMANIAL COMPOUNDS, COMPOSITIONS AND USE THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2023-11-30 — — WO claimed
US-20230381142-A1 ANTILEISHMANIAL COMPOUNDS, COMPOSITIONS AND USE THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2023-11-30 — — US claimed
US-20230339904-A1 ISOINDOLINONES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. 2023-10-26 — — US claimed
CN-116462671-A N- (tert-butyl) -2- (N-acetamido) formamide compound and preparation method and application thereof 陕西盘龙药业集团股份有限公司 2023-07-21 — — CN claimed
CN-115010653-A Metal double terpyridyl ligand, ruthenium-containing supramolecular compound, and preparation method and application thereof 江苏师范大学 2022-09-06 — — CN claimed
US-10772874-B2 Compounds and compositions for the inhibition of NAMPT VALO HEALTH, INC. 2020-09-15 — — US claimed
US-10752609-B2 GSK-3 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2020-08-25 — — US claimed
US-20200071326-A1 TAM KINASE INHIBITORS SYROS PHARMACEUTICALS INC (US) 2020-03-05 — — US claimed
WO-1995012611-A1 ENDOTHELIN RECEPTOR ANTAGONISTS JAPAT LTD. (CH) 1995-05-11 — — WO claimed
EP-0171037-B1 3-CARBONYL-1-AMINOALKYL-1H-INDOLES USEFUL AS ANALGESICS AND PREPARATION THEREOF STERLING WINTHROP INC. (US) 1992-06-17 — — EP claimed
US-5026848-A Antirhinovirus agents SYNPHAR LABORATORIES INCORPORATED (CA) 1991-06-25 — — US claimed
US-5013732-A Analgesics STERLING DRUG INC. (US) 1991-05-07 — — US claimed
US-4978664-A Analgesic, anti-rheumatic, and anti-inflammatory agent STERLING DRUG INC. (US) 1990-12-18 — — US claimed
US-4885295-A ANALGESICS; ANTIINFLAMMATORY AGENTS; RHEUMATIC DISEASES STERLING DRUG INC. (US) 1989-12-05 — — US claimed
US-RE32761-E ANALGESICS, ANTIRHEUMATIC AND ANTIINFLAMMATORY AGENT STERLING DRUG INC. (US) 1988-10-04 — — US claimed
US-4634776-A ANALGESIC, ANTIRHEUMATIC, ANTIINFLAMMATORY STERLING DRUG, INC. (US) 1987-01-06 — — US claimed
US-4581354-A ANALGESICS;ANTI-RHEUMATIC AND ANTI-INFLAMMATORY AGENTS STERLING DRUG INC. (US) 1986-04-08 — — US claimed
EP-0171037-A2 3-Carbonyl-1-aminoalkyl-1H-indoles useful as analgesics and preparation thereof STERLING WINTHROP INC. (US) 1986-02-12 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339904-A1 ISOINDOLINONES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS CSNK1A1, CSNK1D, CSNK1G1 CYP3A4 3764/4885LMNA 4433/4885MAPT 922/4885
US-20200071326-A1 TAM KINASE INHIBITORS PIK3CA, MAP3K1, MAP3K5 CYP3A4 2740/4885LMNA 3103/4885MAPT 2002/4885
US-20230381142-A1 ANTILEISHMANIAL COMPOUNDS, COMPOSITIONS AND USE THEREOF MPO, SSB, SGMS2 CYP3A4 3185/4885LMNA 1217/4885MAPT 2637/4885
US-20240174603-A1 MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME PPM1A, PPP2CA, PPP3CA CYP3A4 4298/4885LMNA 4461/4885MAPT 927/4885
US-10772874-B2 Compounds and compositions for the inhibition of NAMPT NAMPT, NNMT, NQO1 CYP3A4 1137/4885LMNA 923/4885MAPT 268/4885
US-10752609-B2 GSK-3 inhibitors GSK3B, GSK3A, GSKIP CYP3A4 2645/4885LMNA 1497/4885MAPT 90/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.